81 related articles for article (PubMed ID: 3233154)
1. [High specificity in the molecular mechanism of the protective action of phosphocreatine on the myocardium in ischemia].
Saks VA; Makhotina LA; Lakomkin VL; Shteĭnshneĭder AIa; Kapel'ko VI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):42-50. PubMed ID: 3233154
[TBL] [Abstract][Full Text] [Related]
2. [The role of calcium ions in the molecular mechanism of the protective mechanism of exogenous phosphocreatine].
Dzhaliashvili IV; Konorev EA; Medvedeva NV; Lakomkin VL; Saks VA
Biokhimiia; 1992 Feb; 57(2):300-11. PubMed ID: 1326338
[TBL] [Abstract][Full Text] [Related]
3. [Molecular and cellular aspects of the cardioprotective mechanism of phosphocreatine].
Saks VA; Dzhaliashvili IV; Konorev EA; Strumia E
Biokhimiia; 1992 Dec; 57(12):1763-84. PubMed ID: 1294251
[TBL] [Abstract][Full Text] [Related]
4. [Effect of phosphocreatine on the lysophosphoglyceride levels in total ischemia of the rat myocardium].
Dzhavadov SA; Preobrazhenskiĭ AN; Saks VA
Biokhimiia; 1986 Apr; 51(4):668-74. PubMed ID: 3708016
[TBL] [Abstract][Full Text] [Related]
5. [Oxidative damage to the myocardium: the protective action of exogenous phosphocreatine].
Konorev EA; Saks VA; Sharov VG; Makhotina LA
Biull Eksp Biol Med; 1990 Mar; 109(3):224-6. PubMed ID: 2364142
[TBL] [Abstract][Full Text] [Related]
6. [Membranotropic effect of phosphocreatine and its structural analogs].
Konorev EA; Medvedeva NV; Dzhaliashvili IV; Stepanov VA; Saks VA
Biokhimiia; 1991 Sep; 56(9):1701-9. PubMed ID: 1660733
[TBL] [Abstract][Full Text] [Related]
7. Participation of calcium ions in the molecular mechanism of cardioprotective action of exogenous phosphocreatine.
Konorev EA; Medvedeva NV; Jaliashvili IV; Lakomkin VL; Saks VA
Basic Res Cardiol; 1991; 86(4):327-39. PubMed ID: 1659804
[TBL] [Abstract][Full Text] [Related]
8. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization.
Prabhakar G; Vona-Davis L; Murray D; Lakhani P; Murray G
J Am Coll Surg; 2003 Nov; 197(5):786-91. PubMed ID: 14585415
[TBL] [Abstract][Full Text] [Related]
9. [Prospects for correcting the disrupted status of the cardiovascular system in acute myocardial ischemia by combined experimental use of phosphocreatine and corinfar].
Kamilova UK; Kacharava VG; Vititnova MB; Saks VA; Kryzhanovskiĭ SA
Vopr Med Khim; 1991; 37(5):66-8. PubMed ID: 1759404
[TBL] [Abstract][Full Text] [Related]
10. [Effect of phosphocreatine on the blood supply of the ischemic myocardium].
Kryzhanovskiĭ SA; Kandelaki IN; Kaverina NV; Vititnova MB; Saks VA
Fiziol Zh (1978); 1988; 34(4):84-6. PubMed ID: 3181516
[No Abstract] [Full Text] [Related]
11. [The anti-ischemic properties of verapamil and its effect on myocardial functional potentials in coronary artery occlusion].
Paperno AA; Kovalev GV; Gurbanov KG
Farmakol Toksikol; 1991; 54(2):26-8. PubMed ID: 1884790
[TBL] [Abstract][Full Text] [Related]
12. [Study of the protective effect of phosphocreatine on the ischemic myocardium during cardioplegia using the P-31 NMR method].
Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Ruuge EK; Kapel'ko VI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):14-9. PubMed ID: 4005052
[TBL] [Abstract][Full Text] [Related]
13. [Various aspects of protective effect of exogenous phosphocreatine on the ischemic myocardium].
Dzhavadov SA; Preobrazhenskiĭ AN; Lakomkin VL; Kupriianov VV; Saks VA
Vestn Akad Med Nauk SSSR; 1986; (12):58-67. PubMed ID: 3825277
[No Abstract] [Full Text] [Related]
14. Effect of phosphocreatine and related compounds on the phospholipid metabolism of ischemic heart.
Anyukhovsky EP; Javadov SA; Preobrazhensky AN; Beloshapko GG; Rosenshtraukh LV; Saks VA
Biochem Med Metab Biol; 1986 Jun; 35(3):327-34. PubMed ID: 3718764
[TBL] [Abstract][Full Text] [Related]
15. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies.
Sharov VG; Saks VA; Kupriyanov VV; Lakomkin VL; Kapelko VI; Steinschneider AYa ; Javadov SA
J Thorac Cardiovasc Surg; 1987 Nov; 94(5):749-61. PubMed ID: 3669703
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin.
Zhu P; Zaugg CE; Simper D; Hornstein P; Allegrini PR; Buser PT
Cardiovasc Res; 1995 May; 29(5):658-63. PubMed ID: 7606754
[TBL] [Abstract][Full Text] [Related]
17. [The anti-arrhythmic action of exogenous creatine phosphate and its effect on myocardial electrophysiological parameters in acute heart failure].
Khanina NIa; Savel'ev VA; Vikulova OV
Eksp Klin Farmakol; 1993; 56(2):26-8. PubMed ID: 8348031
[TBL] [Abstract][Full Text] [Related]
18. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of protecting the myocardium against ischemia with a normothermic cardioplegic solution and creatine phosphate].
Popov IuV; Saprygin DB; Egorova IF; Kashtélian LS; Bakuleva NP
Biull Eksp Biol Med; 1985 Jan; 99(1):108-10. PubMed ID: 3967061
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
Goldshteĭne GKh; Chichkanov GG
Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
